A carregar...
Therapeutic administration of orlistat, rosiglitazone or the chemokine receptor antagonist RS102895 fails to improve the severity of acute pancreatitis in obese mice
OBJECTIVES: Currently there is no therapy for severe acute pancreatitis except for supportive care. The lipase inhibitor orlistat, the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone, and chemokine receptor-2 antagonists attenuate the severity of acute pancreatitis in rodents...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4151050/ https://ncbi.nlm.nih.gov/pubmed/24632545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000000115 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|